- Home
- ECO vs ATRC Comparison
ECO vs ATRC Comparison
Compare ECO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECO
- ATRC
- Stock Information
- Founded
- ECO 2018
- ATRC 2000
- Country
- ECO Greece
- ATRC United States
- Employees
- ECO N/A
- ATRC N/A
- Industry
- ECO
- ATRC Medical/Dental Instruments
- Sector
- ECO
- ATRC Health Care
- Exchange
- ECO Nasdaq
- ATRC Nasdaq
- Market Cap
- ECO 977.7M
- ATRC 1.1B
- IPO Year
- ECO N/A
- ATRC 2005
- Fundamental
- Price
- ECO $23.66
- ATRC $35.03
- Analyst Decision
- ECO Strong Buy
- ATRC Strong Buy
- Analyst Count
- ECO 1
- ATRC 9
- Target Price
- ECO $44.00
- ATRC $43.11
- AVG Volume (30 Days)
- ECO 196.0K
- ATRC 728.7K
- Earning Date
- ECO 11-08-2024
- ATRC 10-29-2024
- Dividend Yield
- ECO 14.62%
- ATRC N/A
- EPS Growth
- ECO N/A
- ATRC N/A
- EPS
- ECO 3.63
- ATRC N/A
- Revenue
- ECO $399,710,831.00
- ATRC $447,573,000.00
- Revenue This Year
- ECO N/A
- ATRC $17.75
- Revenue Next Year
- ECO $15.33
- ATRC $13.44
- P/E Ratio
- ECO $6.52
- ATRC N/A
- Revenue Growth
- ECO N/A
- ATRC 17.56
- 52 Week Low
- ECO $22.80
- ATRC $18.94
- 52 Week High
- ECO $36.69
- ATRC $43.00
- Technical
- Relative Strength Index (RSI)
- ECO 28.84
- ATRC 60.08
- Support Level
- ECO $22.80
- ATRC $33.08
- Resistance Level
- ECO $24.87
- ATRC $38.34
- Average True Range (ATR)
- ECO 0.78
- ATRC 1.47
- MACD
- ECO -0.13
- ATRC -0.01
- Stochastic Oscillator
- ECO 13.54
- ATRC 67.13
About ECO Okeanis Eco Tankers Corp.
Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers, and eight VLCC tankers.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.